Filing Details
- Accession Number:
- 0001209191-20-002279
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-01-07 16:31:01
- Reporting Period:
- 2020-01-03
- Accepted Time:
- 2020-01-07 16:31:01
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1419600 | Flexion Therapeutics Inc | FLXN | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1296999 | David Arkowitz | C/O Flexion Therapeutics, Inc. 10 Mall Road, Suite 301 Burlington MA 01803 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2020-01-03 | 3,095 | $0.00 | 88,481 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- Sale of shares to cover tax withholding obligations associated with the vesting of a restricted stock unit award granted to the Reporting Person on March 1, 2019.
- The shares were sold at a range of prices between $19.76 and $19.91. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.